← Research LibraryThe BriefFY2025 20-F · headline figures audited against SEC data
Elbit Systems grew revenue 16.3% to $7.94B on munitions demand in Israel and Europe, lifted net income 66.4% to $0.53B, and ended 2025 with a $28.1 billion backlog, 72% of it outside Israel.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +16.3% to $7.94B; Land segment +38%OK
- Profitability — Operating margin 8.5%, +130 bps; net income +66.4%OK
- Balance sheet — $573M net share offering; equity +26.0%OK
- Accounting quality — No manipulation flag; earnings quality safe; Altman-Z greyNote
- Capital allocation — Dividends $0.11B, +25.6%; no buybacksNote
- Backlog — Backlog $28.1B, from $22.6BOK
Business
Elbit Systems, based in Haifa, develops and supplies airborne, land and naval defense systems, munitions, electronic warfare, command and control and homeland security products, plus training and support services. Most revenue comes from governments: the Israeli Ministry of Defense was 28% of 2025 revenue and the U.S. government 15%.
Where the revenue comes from
Fiscal 2025, as ELBIT SYSTEMS LTD reports it. History and quarterly detail are in the app.
- Revenue from sale of products$7.3B
- Service revenue$640.4M
Latest filings
- 6-K · Company announcement (foreign filer)2026-09-18
- 6-K · Company announcement (foreign filer)2026-09-01
- 6-K · Company announcement (foreign filer)2026-08-11
- 6-K · Company announcement (foreign filer)2026-08-06
- 6-K · Company announcement (foreign filer)2026-07-20
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ELBIT SYSTEMS LTD, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.